目前对Graves轨道病的治疗方法 - 向疗法是未来吗?
Anja Eckstein1, Mareile Stöhr1, Gina-Eva Görtz2
1Klinik für Augenheilkunde, Universitätsklinikum Essen, Deutschland.
概括
作为一种自身免疫性眼睛疾病的Graves'轨道病,与Graves'甲状腺功能增强症和TSH受体自身抗体 (TRAb) 有关. 针对IGF1R受体的新疗法有望减少眼睛突起,但长期抑制抗体至关重要.
科学领域:
- 眼科医生 眼科 眼科
- 内分泌学 在内分泌学.
- 免疫学 免疫学 免疫学
背景情况:
- 格雷夫斯轨道病 (GO) 是一种自身免疫性疾病,通常伴随着格雷夫斯甲状腺功能障碍.
- 甲状腺刺激激素受体自身抗体 (TRAb) 是GO诊断和发病的关键,驱动甲状腺功能升和轨道炎症.
- GO表现为周期性胀,外眼,以及由于眼肌纤维化而导致的限制性运动.
研究的目的:
- 审查目前对格雷夫斯轨道病的理解和治疗策略.
- 要突出胰岛素样生长因子1受体 (IGF1R) 在GO病变发生中的作用.
- 评估针对IGF1R.的新生物药物的疗效和副作用.
主要方法:
- 关于格雷夫斯轨道病变的病原和治疗现有文献的综述.
- 分析TRAb和IGF1R在疾病发展中的作用.
- 对IGF1R抑制剂特鲁马布 (teprotumumab) 的临床数据的评估.
主要成果:
- 一种IGF1R抑制剂Teprotumumab在减少GO患者的外眼瘤方面表现出显著的疗效.
- 潜在的副作用包括高血糖和听力损失.
- 抗IGF1R剂对潜在的自身免疫反应 (TRAb产生) 的影响需要进一步研究.
结论:
- 用teprotumumab等药物准IGF1R为格雷夫斯轨道病症提供了一个有前途的治疗途径,特别是在外眼缩方面.
- 长期管理策略必须考虑疾病复发的可能性和持续抗体抑制的需要.
- 需要进一步的研究来阐明IGF1R抑制对GO自身免疫机制的全部影响.
相关概念视频
Open Angle Glaucoma: Treatment
472
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
472
Angle Closure Glaucoma: Treatment
546
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
546
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cholinergic Antagonists: Therapeutic Uses
761
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
761
Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K
Glaucoma: Overview
604
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
604


